Skip to main content
. 2017 Aug 10;34(9):160. doi: 10.1007/s12032-017-1014-2

Fig. 3.

Fig. 3

Adjusted hazard ratios for overall survival by subgroup for patients receiving second-line chemotherapy versus second-line androgen receptor-targeted therapy. aHR adjusted hazard ratio, ALP alkaline phosphatase, CI confidence interval, LDH lactate dehydrogenase, LLN lower limit of normal, PSA prostate-specific antigen, ULN upper limit of normal. a Based on Halabi et al. [18]. * Denotes significant p value at the 5% level